# Simplified Anti-Thrombotic Therapy for FFR

> **NCT02384070** · NA · COMPLETED · sponsor: **Odessa Heart Institute** · enrollment: 300 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **PROCEDURE:** FFR
- **DRUG:** Aspirin
- **DRUG:** Clopidogrel
- **DRUG:** Bivalirudin

## Key facts

- **NCT ID:** NCT02384070
- **Lead sponsor:** Odessa Heart Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2013-12
- **Final completion:** 2014-12
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2017-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02384070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02384070, "Simplified Anti-Thrombotic Therapy for FFR". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02384070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*